Bone Loss in Melanoma Survivors Receiving Immunotherapy

NCT04516122 · clinicaltrials.gov ↗

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped \<75% participation

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Pathologic Stage III Cutaneous Melanoma AJCC v8
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Pathologic Stage IV Cutaneous Melanoma AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Dual X-ray Absorptiometry

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]